Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: Distinguishing influence of exon 19 deletion on radiographic features-Reference-Cited by-同舟云学术

Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: Distinguishing influence of exon 19 deletion on radiographic features

Published:2012-07 Issue:1 Volume:77 Page:64-69
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Sekine Akimasa,Kato Terufumi,Hagiwara Eri,Shinohara Takeshi,Komagata Takanobu,Iwasawa Tae,Satoh Hiroaki,Tamura Katsumi,Kasamatsu Tomotaka,Hayashihara Kenji,Saito Takefumi,Takahashi Hiroshi,Ogura Takashi

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference33 articles.

1. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

2. Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan;Ohe;Ann Oncol,2007

3. Current approaches to advanced-stage non-small-cell lung cancer: first-line therapy in patients with a good functional status;Stinchcombe;Clin Lung Cancer,2006

4. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis;Sorensen;J Clin Oncol,1988

5. Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors;Zabel;Lung Cancer,2002

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of clinical and MRI features of brain metastases between ALK+ and ALK‐ NSCLC;Cancer Medicine;2024-06

2. MRI radiomics for predicting intracranial progression in non-small-cell lung cancer patients with brain metastases treated with epidermal growth factor receptor tyrosine kinase inhibitors;Clinical Radiology;2024-04

3. 2021 WHO Classification of Lung Cancer: Molecular Biology Research and Radiologic-Pathologic Correlation;RadioGraphics;2024-03-01

4. Distinct Progression and Efficacy of First-Line Osimertinib Treatment According to Mutation Subtypes in Metastatic NSCLC Harboring EGFR Mutations;JTO Clinical and Research Reports;2024-02

5. Peritumoural MRI radiomics signature of brain metastases can predict epidermal growth factor receptor mutation status in lung adenocarcinoma;Clinical Radiology;2024-02